Signal active
Bio
Jill joined SR One in 2011 with a background in biotech partnering and commercial development.
Prior to SR One, Jill was responsible for Corporate Development at Dynavax Technologies, where she was involved in multiple pharma partnering deals as well as substanial private and public financings.
Previously, Jill was a consultant specializing in health care at Clearview Projects and Mercer Management Consulting.
Jill received her BS in Chemistry from Duke University, and her MS in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University.
Location
N/A
Social
Primary Organization
1985
190
60
58
1-10
Financial Services, Venture Capital, Finance, Health Care
Jobs history
3
Avalyn Pharma
Board Member
Invalid date - Current
Odyssey Therapeutics
Board Member
Invalid date - Current
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Jill Carroll is the Partner at SR One, based in United States, North America. With a background in Financial Services, Jill Carroll has a rich history of leadership and innovation. Jill Carroll studied BS Chemistry @ Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Nov 29, 2021 | - | Series C - HotSpot Therapeutics | SR One | 100.0M |
Dec 07, 2021 | Odyssey Therapeutics | Series A - Odyssey Therapeutics | SR One | 218.0M |
Oct 13, 2022 | Odyssey Therapeutics | Series B - Odyssey Therapeutics | SR One | 168.0M |
Sep 27, 2023 | Avalyn Pharma | Series C - Avalyn Pharma | SR One | 175.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.